$71.19
0.10.14%
At close: -
$71.19
0.000.00%
After Hours: 4:47 PM EDT
Comments
Loading...
Edwards Lifesciences Stock Guidance | NYSE:EW | Benzinga
Edwards Lifesciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/11/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.45 | $5.60B | $6.00B | $5.84B | Get Alert |
| 02/11/2025 | EW | Edwards Lifesciences | Q1 | 2025 | $0.58 | $0.64 | $0.59 | $1.35B | $1.43B | $1.42B | Get Alert |
| 12/04/2024 | EW | Edwards Lifesciences | FY | 2024 | — | — | — | $6.49B | $6.61B | $5.83B | Get Alert |
| 12/04/2024 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.47 | $5.60B | $6.00B | $5.92B | Get Alert |
| 10/24/2024 | EW | Edwards Lifesciences | FY | 2024 | — | — | — | $6.49B | $6.61B | $6.13B | Get Alert |
| 10/24/2024 | EW | Edwards Lifesciences | Q4 | 2024 | $0.53 | $0.57 | $0.62 | $1.33B | $1.39B | $1.44B | Get Alert |
| 07/24/2024 | EW | Edwards Lifesciences | Q3 | 2024 | $0.67 | $0.71 | $0.69 | $1.56B | $1.64B | $1.62B | Get Alert |
| 04/25/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.75 | $6.60B | $6.60B | $6.52B | Get Alert |
| 04/25/2024 | EW | Edwards Lifesciences | Q2 | 2024 | $0.67 | $0.71 | $0.70 | $1.62B | $1.70B | $1.64B | Get Alert |
| 02/06/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.76 | $6.30B | $6.60B | $6.48B | Get Alert |
| 02/06/2024 | EW | Edwards Lifesciences | Q1 | 2024 | $0.62 | $0.66 | $0.66 | $1.53B | $1.61B | $1.56B | Get Alert |
| 12/07/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.47 | $2.53 | $2.51 | $5.90B | $6.10B | $5.97B | Get Alert |
| 12/07/2023 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.80 | $6.30B | $6.60B | $6.51B | Get Alert |
| 10/25/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.92B | $6.08B | $6.00B | Get Alert |
| 10/25/2023 | EW | Edwards Lifesciences | Q4 | 2023 | $0.60 | $0.66 | $0.68 | $1.45B | $1.53B | $1.54B | Get Alert |
| 07/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.90B | $6.10B | $5.96B | Get Alert |
| 07/26/2023 | EW | Edwards Lifesciences | Q3 | 2023 | $0.55 | $0.61 | $0.63 | $1.44B | $1.52B | $1.47B | Get Alert |
| 04/26/2023 | EW | Edwards Lifesciences | Q2 | 2023 | $0.62 | $0.68 | $0.63 | $1.48B | $1.56B | $1.46B | Get Alert |
| 04/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.48 | $2.60 | $2.52 | $6.00B | $6.00B | $5.85B | Get Alert |
| 01/31/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.50 | $5.60B | $6.00B | $5.78B | Get Alert |
| 01/31/2023 | EW | Edwards Lifesciences | Q1 | 2023 | $0.58 | $0.64 | $0.59 | $1.37B | $1.45B | $1.37B | Get Alert |
| 12/08/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.45 | $5.35B | $5.35B | $5.36B | Get Alert |
| 12/08/2022 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.52 | $5.60B | $6.00B | $5.71B | Get Alert |
| 10/27/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.51 | $5.35B | $5.35B | $5.47B | Get Alert |
| 07/28/2022 | EW | Edwards Lifesciences | Q3 | 2022 | $0.58 | $0.66 | $0.65 | $1.30B | $1.37B | $1.44B | Get Alert |
| 07/28/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.50 | $2.56 | $5.35B | $5.55B | $5.71B | Get Alert |
| 04/26/2022 | EW | Edwards Lifesciences | Q2 | 2022 | $0.61 | $0.69 | $0.65 | $1.36B | $1.44B | $1.46B | Get Alert |
| 04/26/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.55 | $5.50B | $6.00B | $5.76B | Get Alert |
| 01/26/2022 | EW | Edwards Lifesciences | Q1 | 2022 | $0.54 | $0.62 | $0.60 | $1.27B | $1.35B | $1.36B | Get Alert |
| 01/26/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.58 | $5.50B | $6.00B | $5.82B | Get Alert |
| 12/08/2021 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.58 | $5.50B | $6.00B | $5.85B | Get Alert |
| 10/27/2021 | EW | Edwards Lifesciences | Q4 | 2021 | $0.53 | $0.59 | $0.56 | $1.30B | $1.38B | $1.41B | Get Alert |
| 10/27/2021 | EW | Edwards Lifesciences | FY | 2021 | $2.07 | $2.27 | $2.26 | $5.20B | $5.40B | $5.32B | Get Alert |
| 07/29/2021 | EW | Edwards Lifesciences | FY | 2021 | $2.27 | $2.27 | $2.21 | $5.20B | $5.40B | $5.17B | Get Alert |
| 07/29/2021 | EW | Edwards Lifesciences | Q3 | 2021 | $0.50 | $0.56 | $0.55 | $1.29B | $1.37B | $1.30B | Get Alert |
| 04/20/2021 | EW | Edwards Lifesciences | FY | 2021 | $2.07 | $2.27 | $2.13 | $4.90B | $5.30B | $5.08B | Get Alert |
| 04/20/2021 | EW | Edwards Lifesciences | Q2 | 2021 | $0.54 | $0.60 | $0.52 | $1.25B | $1.33B | $1.25B | Get Alert |
| 01/27/2021 | EW | Edwards Lifesciences | Q1 | 2021 | $0.43 | $0.50 | $0.50 | $1.10B | $1.20B | $1.21B | Get Alert |
| 01/27/2021 | EW | Edwards Lifesciences | FY | 2021 | $2.00 | $2.20 | $2.15 | $4.90B | $5.30B | $5.09B | Get Alert |
| 12/10/2020 | EW | Edwards Lifesciences | FY | 2021 | $2.00 | $2.20 | $2.22 | $4.90B | $5.30B | $5.10B | Get Alert |
| 10/21/2020 | EW | Edwards Lifesciences | FY | 2020 | $1.85 | $1.95 | $1.84 | — | — | — | Get Alert |
| 07/23/2020 | EW | Edwards Lifesciences | Q3 | 2020 | — | — | — | $1.00B | $1.20B | $1.04B | Get Alert |
| 07/23/2020 | EW | Edwards Lifesciences | FY | 2020 | $1.75 | $1.95 | $1.63 | $4.00B | $4.50B | $4.23B | Get Alert |
FAQ
What is the most recent guidance for Edwards Lifesciences (EW)?
The most recent guidance for Edwards Lifesciences (EW) was reported on February 11, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $2.40 to $2.50, compared to the estimated EPS of $2.45. Additionally, Edwards Lifesciences forecasted revenue between $5.60B and $6.00B for the quarter.
Browse guidance and forecast on all stocks.